Abstract
Ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS) is a cause of Cushing’s syndrome usually associated with neuroendocrine tumors. Olfactory neuroblastoma (ONB) is a rare malignant neoplasm of the olfactory epithelium. This is the case of a 56-year-old woman with an ONB presenting with EAS. After initiating metyrapone, she developed a Pneumocystis jirovecii pneumonia. Following successful treatment of the infection, she underwent surgical tumor excision and radiotherapy, which has been in remission for the past 3 years. The authors provide a literature review of the 30 previously published cases of ONB presenting with EAS. Most were reported in middle-aged men, with a recurrence rate of 15.6% (3 patients eventually died). A total of 9.5% of all reported had an infection after starting corticosteroid-blocking therapy. ONB is a very rare cause of EAS with poor prognosis and a relapsing course. In the presence of severe hypercortisolism, chemoprophylaxis for common opportunistic agents must be considered.
Summary
Ectopic adrenocorticotropic hormone secretion syndrome (ACES) is a cause of Cushing’s syndrome commonly associated with neuroendocrine tumors. Olfactory neuroblastoma (ON) is a rare malignant tumor of the olfactory epithelium. We describe the case of a 56-year-old woman with ACES secondary to ON. After starting metyrapone, the patient developed Pneumocystis jirovecii pneumonia . The infection was treated, the tumor was surgically removed, and she received radiotherapy. The patient has maintained remission for the past 3 years. We review the 30 previously reported cases of ACEs secondary to ON. Most occurred in middle-aged men, with a recurrence rate of 15.6% (3 patients died). Ninety-five percent of these cases had an infection after starting control of hypercortisolism. ON is a rare cause of ACEs with a poor prognosis and high recurrence rate. In the presence of hypercortisolism, chemoprophylaxis for common opportunistic agents should be considered.
Access through your organization
Check access to the full text by signing in through your organization.
Section snippets
Case description
Production of adrenocorticotropic hormone (ACTH) from nonpituitary tumors – known as ectopic ACTH syndrome (EAS) – is the cause of ACTH-dependent hypercortisolism in up to 18% of all cases of Cushing’s syndrome. 1 EAS is more commonly associated with neuroendocrine tumors located in the chest, namely small-cell lung carcinoma, bronchial carcinoids and thymic neuroendocrine tumors. 2 These are followed less frequently by breast, colon, gastric, pancreatic and prostate cancers.2, 3, 4, 5, 6
Management and evidence
We consider our case particularly interesting for two reasons: the rarity of an ONB as a cause of the EAS (there are only 30 other cases reported worldwide) (Table 1) 30, 31, 32, 33, 34, 35, 36, 37, 38 and clinical progression with an opportunistic infection after starting corticosteroid-blocking therapy. To identify the 30 cases referenced we performed a literature review across PubMed, until August 2024, using the
Areas of uncertainty
Although there is some doubt about the elevated infectious risk of these patients, not only due to hypercortisolism but also after starting steroid-blocking therapy, diagnosis of these complications is frequently delayed. Additionally, infectious chemoprophylaxis is not routinely instituted in these patients. Our case highlights these areas of discussion.
Once ACTH secretion is detected, steroid-blocking therapy is often initiated to control symptoms related to Cushing’s syndrome. Metyrapone and
Guidelines
Due to the rarity of ONB presenting with ACTH secretion, there are no specific and well-established guidelines that delineate the management of these conditions presenting simultaneously, but there are recommendations for the treatment of each of them separately.2, 13, 45, 46
Regarding ONB management, surgery must be considered whenever it is feasible, and adjuvant radiotherapy is recommended in every case.13, 46 Adjuvant and neoadjuvant chemotherapy can be considered, depending on the initial
Conclusions and recommendations
EAS secretion is a cause of Cushing’s syndrome and should be suspected in the presence of signs and symptoms of severe hypercortisolism, even without the typical Cushing’s syndrome stigmata. Although ONB is a very rare cause of the ACTH syndrome, it should not be missed considering its poor outcome when left untreated. Hypercortisolism should be controlled until it is possible to treat the underlying tumor, bearing in mind that normalizing cortisol levels can precipitate opportunistic
Funding
None declared.
Conflicts of interest
None declared.
References (46)
- T. Rickman et al.
Hypokalemia, metabolic alkalosis, and hypertension: Cushing’s syndrome in a patient with metastatic prostate adenocarcinoma
Am J Kidney Dis
(2001) - F. Zheng et al.
Metastatic adrenocorticotropic hormone-secreting breast cancer treated with bilateral adrenalectomy
AACE Clin Case Rep
(2018) - J. Yu et al.
Ectopic Cushing’s syndrome caused by an esthesioneuroblastoma
Endocr Pract
(2004) - H. Lin et al.
Refractory post-herpetic neuralgia as an initial presentation of olfactory neuroblastoma-related ectopic ACTH syndrome
Int J Gerontol
(2009) - JY Han et al.
Bilateral adrenalectomy: lifesaving procedure in severe Cushing syndrome
Endocr Pract
(2012) - N. Mayur et al.
Cushing’s syndrome due to ectopic adrenocorticotrophic hormone production by olfactory neuroblastoma
Endocr Pract
(2014) - K. Clotman et al.
An endocrine picture in disguise: a progressive olfactory neuroblastoma complicated with ectopic Cushing syndrome
AACE Clin Case Rep
(2017) - J. Cristante et al.
Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing’s disease
Ann Endocrinol
(2020) - D. Di Carlo et al.
Olfactory neuroblastoma in children and adolescents: the EXPeRT recommendations for diagnosis and management
EJC Paediatric Oncology
(2024) - ST Sharma et al.
Cushing’s syndrome: epidemiology and developments in disease management
Clin Epidemiol
(2015)
Filed under: Cushing's, Rare Diseases, Treatments | Tagged: Ectopic Adrenocorticotropic Hormone Syndrome, hypercortisolism, Metyrapone, olfactory neuroblastoma |
CushieBlog 
Leave a comment